@article{ETD,
      recid = {7518},
      author = {Reda, Moataz},
      title = {Development of novel nanoparticle based PLK1, EGFR, and  PD-L1 targeted therapies for lung cancer},
      publisher = {Oregon Health and Science University},
      school = {Ph.D.},
      address = {2019},
      number = {ETD},
      abstract = {Non-small cell lung cancer (NSCLC) is the deadliest form  of cancer and represents nearly a fourth of all cancer  related deaths worldwide. Identifying molecular targets and  developing effective therapeutic regimens to improve NSCLC  treatments and patient quality of life is needed.  Nanoparticles possess unique properties to enhance  treatment efficacy and reduce toxic side effects of  traditional therapies. In my dissertation, I exploited  versatile mesoporous silica nanoparticles (MSNP) to improve  radiation therapy and immunotherapy, which are two key  treatments for NSCLC patients.},
      url = {http://digitalcollections.ohsu.edu/record/7518},
      doi = {https://doi.org/10.6083/n583xv58g},
}